ATBPF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Antibe Therapeutics (ATBPF) Ownership - Who owns Antibe Therapeutics?

Antibe Therapeutics Inc is leveraging its proprietary hydrogen sulfide platform to develop next-generation safer therapies to target inflammation arising from a wide range of medical conditions... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

15 Prince Arthur Avenue

Phone

+1 905 570-5103

Employees

Web

https://www.antibethera.com

Details

Group

Domestic Stock Funds

Fundamentals

ATBPF

Capitalization

11.4M

P/E Ratio

N/A

Risk (Beta)

0.75

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

0.60

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

53M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

0.000

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology